Infants at high risk for developing allergic diseases may see a reduced risk of food allergies and atopic dermatitis when fed a whey-based partially hydrolyzed formula during their first six months of life, according to research published in Pediatric Allergy and Immunology. A five-year follow-up of 455 infants found that those receiving this specific formula had lower rates of allergic manifestations compared to infants fed standard cow’s milk-based formula.
Impact of Partially Hydrolyzed Formula on Allergy Development
Clinical data from the Allergy Reduction Trial (A.R.T.) indicates that partially hydrolyzed formulas can influence the development of childhood allergies. Researchers monitored 455 healthy, full-term infants identified as high-risk due to family history. By the five-year mark, infants fed the partially hydrolyzed whey-based formula showed a significant reduction in the incidence of food allergies and atopic dermatitis compared to those fed standard formula.
Specifically, the study reported that from birth to five years, 10.5% of infants in the partially hydrolyzed group developed food allergies, compared to 20.4% in the standard formula group. Atopic dermatitis rates were also lower, affecting 22.1% of the partially hydrolyzed group versus 38.5% of the standard formula group. These findings align with the growing body of evidence regarding the "hygiene hypothesis" and the role of early dietary proteins in immune system modulation, as noted by the American Academy of Pediatrics in its guidance on hypoallergenic feeding.
Understanding the Role of Mixed Feeding
A significant portion of the infants in the study—nearly 90%—were "mixed-fed," meaning they received both breast milk and formula. Lead researcher Mikaela Sekkidou and colleagues suggest that this combination, specifically the regular ingestion of partially hydrolyzed formula during the first months of life alongside breastfeeding, likely contributed to the observed reduction in allergic outcomes.
While the study showed clear benefits for atopic dermatitis and food allergies, it did not find a significant preventative effect for asthma or allergic rhinitis. In some cohorts, the rates for these respiratory conditions were slightly higher in the partially hydrolyzed group, though researchers noted these differences were not statistically significant.
Clinical Considerations for Parents
When evaluating infant feeding options, pediatricians often weigh the risks of allergic sensitization against the nutritional requirements of the child. It is important to distinguish between "partially hydrolyzed" formulas, which are designed for allergy prevention in high-risk infants, and "extensively hydrolyzed" formulas, which are therapeutic options for infants already diagnosed with cow’s milk protein allergy.
The study authors emphasize that these results, while promising, should be viewed as part of an evolving evidence base. Larger, multicenter, prospective randomized controlled trials are required to establish definitive clinical guidelines. Parents concerned about allergy risks should consult with their pediatrician or a board-certified allergist to discuss the appropriate feeding strategy based on their child’s specific family history and health profile.
Frequently Asked Questions
- What is the difference between partially and extensively hydrolyzed formula? Partially hydrolyzed formulas contain proteins broken down into smaller pieces, which may help the immune system tolerate them better. Extensively hydrolyzed formulas are broken down much further and are typically used for infants who have already been diagnosed with a milk protein allergy.
- Does this study suggest formula is better than breast milk? No. The study highlights the benefits of a combination approach. Breastfeeding remains the gold standard for infant nutrition, and the researchers observed that most participants were successfully mixed-feeding.
- Are these findings applicable to all infants? The study specifically focused on infants at "high risk" for allergy development. Results may differ for infants with no family history of allergic disease.